Abstract
This article attempts to look into the dynamics of a national system of biotechnology innovation (NSBI) in the wider framework of its role in economic development. It has been found that NSBI crucially depends not only on budgetary allocations and institutional support for advancement, but also on response to market demand. The evidence from Singapore shows that a sectoral approach in NSBI may help developing countries in finding a niche for growth instead of broadening the area of investment within biotechnology. In case of Singapore, the biomedical sector has been chosen by the national government for achieving the desired growth rate in the manufacturing sector. The various components of the NSBI and specific achievements of Singapore in this regard have been discussed in the article.
Get full access to this article
View all access options for this article.
